Shandong Sinobioway Biomedicine Balance Sheet Health
Financial Health criteria checks 4/6
Shandong Sinobioway Biomedicine has a total shareholder equity of CN¥2.2B and total debt of CN¥10.0M, which brings its debt-to-equity ratio to 0.5%. Its total assets and total liabilities are CN¥2.3B and CN¥116.1M respectively.
Key information
0.5%
Debt to equity ratio
CN¥10.00m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥434.39m |
| Equity | CN¥2.15b |
| Total liabilities | CN¥116.06m |
| Total assets | CN¥2.27b |
Recent financial health updates
No updates
Recent updates
There's Reason For Concern Over Shandong Sinobioway Biomedicine Co., Ltd.'s (SZSE:002581) Massive 43% Price Jump
Oct 08
Shandong Sinobioway Biomedicine Co., Ltd.'s (SZSE:002581) Business Is Yet to Catch Up With Its Share Price
Aug 19Shandong Sinobioway Biomedicine Co., Ltd.'s (SZSE:002581) 26% Price Boost Is Out Of Tune With Revenues
Mar 06Financial Position Analysis
Short Term Liabilities: 002581's short term assets (CN¥742.3M) exceed its short term liabilities (CN¥86.2M).
Long Term Liabilities: 002581's short term assets (CN¥742.3M) exceed its long term liabilities (CN¥29.8M).
Debt to Equity History and Analysis
Debt Level: 002581 has more cash than its total debt.
Reducing Debt: 002581's debt to equity ratio has reduced from 32.3% to 0.5% over the past 5 years.
Debt Coverage: 002581's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 002581's interest payments on its debt are well covered by EBIT.